The downregulation of ZEB1 in human AML cell lines using short interfering RNA (siRNA) during in vitro study contributed to the expression of myeloid cell surface markers and the halting of cell proliferation, and eventually putting off the onset of tumors in xenograft models, suggesting its role in sustaining AML malignancy. Here, ZEB1 is linked to acute myeloid leukemia.